Grandi Giovanni, Feliciello Lia, Iaccheri Mattia, Melotti Chiara, Anceschi Federica, Facchinetti Fabio
Department of Medical and Surgical Sciences for Mother, Child and Adult, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy -
Department of Medical and Surgical Sciences for Mother, Child and Adult, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy.
Minerva Obstet Gynecol. 2024 Jun;76(3):250-256. doi: 10.23736/S2724-606X.24.05432-0.
Pelvic congestion syndrome (PCS) is associated with chronic pelvic pain (CPP). The efficacy of flavonoids for treating PCS symptoms is still a matter of debate, and little has been published. The aim of this study was to assess the efficacy of a mixture of diosmin, troxerutin, and hesperidin in improving symptoms of patients with PCS, observing a direct effect on circulation by specific color Doppler ultrasonography (CDU) evaluations.
This was a pilot, prospective, independent, cross-over, daily-diary-based trial. Women were evaluated with CDU for 3 times (baseline, 60 days, 120 days). Data about N.=13 women who completed the study were analyzed.
During the treatment, we recorded a significant reduction of intermenstrual and menstrual pain intensity (total points) (P<0.05). The satisfaction after treatment was significantly higher than after placebo (P<0.0001). A significant reduction in the diameter of the major ovarian vein (P=0.004 compared to placebo), associated with an increase in peak systolic velocity (P=0.01) and a corresponding significant increase in the Resistivity Index (P<0.0001) were recorded during treatment.
The use of a mixture of diosmin, troxerutin and hesperidin in women with PCS can significantly help to manage typical symptoms of pelvic pain and it is associated with an evident Doppler effect on pelvic microcirculation.
盆腔淤血综合征(PCS)与慢性盆腔疼痛(CPP)相关。黄酮类化合物治疗PCS症状的疗效仍存在争议,且相关报道较少。本研究的目的是评估地奥司明、曲克芦丁和橙皮苷的混合物在改善PCS患者症状方面的疗效,并通过特定的彩色多普勒超声(CDU)评估观察其对循环的直接影响。
这是一项基于每日日记的前瞻性、独立、交叉试验。对女性进行3次CDU评估(基线、60天、120天)。分析了完成研究的13名女性的数据。
治疗期间,我们记录到经间期和经期疼痛强度(总分)显著降低(P<0.05)。治疗后的满意度显著高于安慰剂组(P<0.0001)。治疗期间记录到主要卵巢静脉直径显著减小(与安慰剂相比,P=0.004),同时收缩期峰值流速增加(P=0.01),阻力指数相应显著增加(P<0.0001)。
在患有PCS的女性中使用地奥司明、曲克芦丁和橙皮苷的混合物可显著有助于控制盆腔疼痛的典型症状,并且与盆腔微循环的明显多普勒效应相关。